Private Medicare Plans Ending: What to Do
Some Medicare Advantage and Part D enrollees may face plan cancellations, higher costs, or narrower networks. Learn how to compare coverage and meet enrollment deadlines.
Free Gemini Users Move to Auto Models
Google is reportedly moving some free Gemini users toward Auto model selection while adding thinking levels that balance response speed and reasoning depth.
How a Times Square Performer Diversified Income
A Times Square performer can turn public visibility into a broader creative business through bookings, digital content, products, audience building, and careful financial tracking.
Google’s Next TV Streamer Could Challenge Apple TV
Google’s next TV Streamer could improve performance, software, storage, and smart-home integration, giving it a stronger challenge against Apple TV.
iPhone Duo: 9 Reasons to Buy Apple’s Foldable
Apple’s rumored iPhone Duo could combine a compact phone with a larger display. Here are the nine strongest reasons to buy it—and the risks to consider.
How AI Open-Source Tools Challenge Adobe
AI-powered open-source tools may replace selected Adobe workflows, reduce subscription costs, and make creative software more adaptive without eliminating traditional applications.
Heart Scan Leads to Early Pancreatic Cancer Diagnosis
An unexpected finding during a routine heart scan led to follow-up testing, a pancreatic cancer diagnosis, and treatment for one woman.
GLP-1 Lawsuits and the Uncertain Risk of Serious Harm
GLP-1 lawsuits allege serious injuries and inadequate warnings, but lawsuits and safety reports cannot establish causation or show how often complications occur.
Cancer Vaccines: Promise, Progress, and Challenges
Cancer vaccines could prevent some cancers, treat existing tumors, and target patient-specific mutations. Most therapeutic and personalized approaches remain experimental.
Could Chemistry Make Switchable Tattoos Possible?
Researchers are exploring tattoos that can change visibility through chemical triggers, but safety, durability, reversibility, and regulation remain unresolved.